Market cap
₹5 Cr
Revenue (TTM)
₹26 Cr
P/E Ratio
--
P/B Ratio
-0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-17 Cr
-
ROE
0 %
-
ROCE
-108.4 %
-
Industry P/E
39.9
-
EV/EBITDA
-34.2
-
Debt to Equity
-1
-
Book Value
₹--
-
EPS
₹-5.9
-
Face value
10
-
Shares outstanding
24,035,151
10 Years Aggregate
CFO
₹65.60 Cr
EBITDA
₹-42.25 Cr
Net Profit
₹-188.43 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
KDL Biotech
| 32.1 | 13.2 | 28.1 | 20.2 | -17.8 | -29.9 | -21.5 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2014
|
|---|---|
|
KDL Biotech
| -15.2 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
KDL Biotech
|
2.1 | 5.1 | -- | -14.2 | -- | -- | -- | -0.1 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About KDL Biotech
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1986
-
Chairman
--
-
Managing Director
Nalin Bamzai
-
Group
Parijat
-
Headquarters
Savroli, Maharashtra
-
Website
FAQs for KDL Biotech
What is the current share price of KDL Biotech Ltd Today?
The share price of KDL Biotech Ltd is ₹2.14 (BSE) and ₹2.50 (NSE) as of 16-Mar-2015 IST. KDL Biotech Ltd has given a return of -17.78% in the last 3 years.
What is the current PB & PE ratio of KDL Biotech Ltd?
Since, TTM earnings of KDL Biotech Ltd is negative, P/E ratio is not available.
The P/B ratio of KDL Biotech Ltd is -0.05 times as on 16-Mar-2015, a 101 discount to its peers’ median range of 4.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2012 |
0.00 |
-0.15 |
2011 |
0.00 |
-0.31 |
2008 |
0.00 |
0.71 |
2004 |
0.00 |
0.60 |
2003 |
7.10 |
0.28 |
What is the 52 Week High and Low of KDL Biotech Ltd?
The 52-week high and low of KDL Biotech Ltd are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of KDL Biotech Ltd?
KDL Biotech Ltd has a market capitalisation of ₹ 5 Cr as on 16-Mar-2015. As per SEBI classification, it is a company.
Should I invest in KDL Biotech Ltd?
Before investing in KDL Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.